Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004770-16Phase 4Completed
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Jens Børglum. Primary endpoint: total opioid dose first 6 hours. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004770-16.